Erythroleukemia Relapsing as Precursor B-cell Lymphoblastic Leukemia
被引:7
|
作者:
Park, Borae G.
论文数: 0引用数: 0
h-index: 0
机构:Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South Korea
Park, Borae G.
Park, Chan-Jeoung
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South KoreaUniv Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South Korea
Park, Chan-Jeoung
[1
]
Jang, Seongsoo
论文数: 0引用数: 0
h-index: 0
机构:Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South Korea
Jang, Seongsoo
Seo, Eul Ju
论文数: 0引用数: 0
h-index: 0
机构:Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South Korea
Seo, Eul Ju
Chi, Hyun-Sook
论文数: 0引用数: 0
h-index: 0
机构:Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South Korea
Chi, Hyun-Sook
Lee, Jung-Hee
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ulsan, Coll Med, Dept Internal Med, Seoul 138736, South KoreaUniv Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South Korea
Lee, Jung-Hee
[2
]
机构:
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Dept Internal Med, Seoul 138736, South Korea
AML relapsing as ALL has rarely been reported. We describe the case of a 62-yr-old man who was diagnosed with erythroleukemia with a complex karyotype and achieved complete hematologic and cytogenetic remission after induction chemotherapy. However, 4 months after the initial diagnosis, he showed relapse with blasts showing a different morphology and immunophenotype and was diagnosed with precursor B-cell ALL The relapsing precursor B-cell ALL presented with the same leukemic clones as the primary erythroleukemia. Cytogenetic analysis of his bone marrow (BM) at the time of the primary erythroleukemia showed complex karyotypic abnormalities, including monosomy 5 and monosomy 7. At relapse, his BM showed reemergence of these leukemic clones of complex karyotypic abnormalities with clonal switch. To our knowledge, this is the first case of a lineage switch from erythroleukemia to ALL.